BWAY
Brainsway LtdNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$674.16M
P/E Ratio
93.56
EPS
$0.18
Beta
0.14
52W High
$16.95
52W Low
$4.30
50-Day MA
$13.84
200-Day MA
$9.87
Dividend Yield
—
Profit Margin
14.50%
Forward P/E
80.00
PEG Ratio
—
About Brainsway Ltd
Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company is headquartered in Jerusalem, Israel.
Fundamentals
| Revenue (TTM) | $52.23M |
| Gross Profit (TTM) | $39.39M |
| EBITDA | $5.12M |
| Operating Margin | 13.20% |
| Return on Equity | 11.20% |
| Return on Assets | 2.60% |
| Revenue/Share (TTM) | $1.37 |
| Book Value | $1.87 |
| Price-to-Book | 9.20 |
| Price-to-Sales (TTM) | 12.91 |
| EV/Revenue | 11.71 |
| EV/EBITDA | 62.31 |
| Quarterly Earnings Growth (YoY) | 321.20% |
| Quarterly Revenue Growth (YoY) | 27.40% |
| Shares Outstanding | $40.03M |
| Float | $27.78M |
| % Insiders | 6.04% |
| % Institutions | 35.22% |
Historical Volatility
HV 10-Day
41.63%
HV 20-Day
63.48%
HV 30-Day
57.96%
HV 60-Day
58.50%
HV Rank
75.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($15.33 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 5/2/2026